Research article2024Peer reviewed
Clinical significance of the TK1 specific activity in the early detection of ovarian cancer
Osredkar, Josko; Jagarlamudi, Kiran Kumar; Cviic, Diana et al.
Kiran Kumar Jagarlamudi
Department of Animal Biosciences
Faculty of Veterinary Medicine and Animal Sciences
ORCID: 0000-0003-1567-5863
Publications
2024
2022
Research article2022Peer reviewedOpen access
Serum thymidine kinase 1 concentration as a predictive biomarker in prostate cancer
Lundgren, Per-Olof; Tribukait, Bernhard; Kjellman, Anders et al.
Research article2022Peer reviewedOpen access
Serum TK1 protein and C-reactive protein correlate to treatment response and predict survival in dogs with hematologic malignancies
Saellstrom, S.; Sharif, H.; Jagarlamudi, K. K. et al.
2019
Research article2019Peer reviewed
The combination of AroCell TK 210 ELISA with Prostate Health Index or prostate-specific antigen density can improve the ability to differentiate prostate cancer from noncancerous conditions
Jagarlamudi, Kiran Kumar; Zupan, Mojca; Kumer, Kristina et al.
2018
Research article2018Peer reviewed
Doxorubicin effects on leukemia and breast cancer cells in culture on the TK1 protein levels using AroCell TK 210 ELISA: a tool for drug development
Jagarlamudi, K. K.; Wang, L.; Eriksson, S..
Review article2018Peer reviewedOpen access
Thymidine kinase 1 as a tumor biomarker: technical advances offer new potential to an old biomarker
Jagarlamudi, Kiran Kumar; Shaw, Martin.
2016
Research article2016Peer reviewedOpen access
A clinical evaluation of the TK 210 ELISA in sera from breast cancer patients demonstrates high sensitivity and specificity in all stages of disease
Kumar, J. Kiran; Aronsson, A. C.; Pilko, G. et al.
2015
Doctoral thesis2015Open access
Diagnostic implications of the molecular forms and levels of serum thymidine kinase 1 in different canine malignancies
Jagarlamudi, Kiran Kumar.
Research article2015Peer reviewedOpen access
A New Sandwich ELISA for Quantification of Thymidine Kinase 1 Protein Levels in Sera from Dogs with Different Malignancies Can Aid in Disease Management : Dog TK1-ELISA
Jagarlamudi, Kiran Kumar; Moreau, Laura; Westberg, Sara et al.
Research article2015Peer reviewedOpen access
Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarker
Jagarlamudi, Kiran Kumar; Hansson, Lars Olof; Eriksson, Staffan.
2014
Conference abstract2014
The new TK 201 ELISA provides prognostic information in patients with breast cancer
Kumar, K. J.; Aronsson, A. C.; Pilko, G. et al.
Research article2014Peer reviewedOpen access
Properties of cellular and serum forms of thymidine kinase 1 (TK1) in dogs with acute lymphocytic leukemia (ALL) and canine mammary tumors (CMTs): implications for TK1 as a proliferation biomarker
Jagarlamudi KK, Westberg S, Ronnberg H, Eriksson S.
2013
Research article2013Peer reviewed
High levels of inactive thymidine kinase 1 polypeptide detected in sera from dogs with solid tumours by immunoaffinity methods: Implications for in vitro diagnostics
Jagarlamudi, Kiran Kumar; Sharif, Hanan; Westberg, Sara et al.
2012
Conference abstract2012Peer reviewed
The increase in serum thymidine kinase 1 subunit levels is more significant than the TK1-activities in samples from patients with solid tumors; implications for disease detection and monitoring efficiency
Jagarlamudi, K-K; Sharif, H.; von Euler, S. H. et al.
Research article2012Peer reviewedOpen access
Quaternary Structures of Recombinant, Cellular and Serum Forms of Thymidine Kinase 1 from Dogs and Humans
Sharif, Hanan; Jagarlamudi, Kiran Kumar; Wang, Liya et al.